Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Background: The pathogenesis of germinal center B-cell type diffuse large B-cell lymphoma (GCB-DLBCL) is not fully elucidated. This study aims to explore the regulation of super enhancers (SEs) on GCB-DLBCL by identifying specific SE-target gene. Methods: Weighted gene co-expression network analysis (WGCNA) was used to screen modules associated with GCB subtype. Functional analysis was performed by gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment. H3K27ac peaks were used to identify SEs. Overall survival analysis was performed using Kaplan–Meier curve with log-rank and Breslow test. The effect of ADNP, ANKRD28 and RTN4IP1 knockdown on Karpas 422 and SUDHL-4 cells proliferation was analyzed by CCK-8. Karpas 422 and SUDHL-4 cells were treated with bromodomain and extra-terminal domain (BET) inhibitor JQ1, and the expression of ADNP, ANKRD28 and RTN4IP1was measured by qRT-PCR. Results: A total of 26 modules were screened in DLBCL. Turquoise module was closely related to GCB-DLBCL, and its eigengenes were mainly related to autophagy. There were 971 SEs in Karpas 422 cell and 1088 SEs in SUDHL-4 cell. Function of the nearest genes of overall SEs were related to cancer. Six SE-related genes associated with GCB-DLBCL were identified as prognostic markers. Knockdown of ADNP, ANKRD28 and RTN4IP1 inhibited the proliferation of Karpas 422 and SUDHL-4 cells. JQ1 treatment suppressed ADNP, ANKRD28 and RTN4IP1 expression in Karpas 422 and SUDHL-4 cells. Conclusions: A total of 6 SE-related genes associated with GCB-DLBCL overall survival were identified in this study. These results will serve as a theoretical basis for further study of gene regulation and function of GCB-DLBCL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Interestingly, systematic analysis summarized 39 prognostic gene signatures for GC patients to detect the most overlapped gene.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143 · cited 1×
“first proposed the concept of super enhancer (SE) on the basis of genome-wide identification and functional characteristics of enhancers [14].”
BackgroundSuper-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662 · cited 1×
“Studies have shown that histone H3K27ac modification is the preferred marker for the identification of super enhancers [17].”
BackgroundSelective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961 · cited 14×
“Compare with normal cells, tumor cells construct SEs on oncogenes during tumorigenesis and recruit enhancer-binding proteins to drive gene expression [16].”
BackgroundInfluentialPott, S., & Lieb, J. D. (2015) · Nature Genetics · doi:10.1038/ng.3167 · Cited by 761 · cited 1×
“SE is a large cluster of transforming activity enhancers that drives the expression of cellular identity gene [15].”
BackgroundLi, S., Young, K. H., & Medeiros, L. J. (2018) · Pathology · doi:10.1016/j.pathol.2017.09.006 · Cited by 649
Genetic heterogeneity of diffuse large B-cell lymphoma
Zhang, J., Grubor, V., Love, C. L., Banerjee, A., Richards, K. L., Mieczkowski, P. A., Dunphy, C., Choi, W., Au, W. Y., Srivastava, G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205299110 · Cited by 527 · cited 1×
“It should be noted that although previous studies have divided DLBCL into three types: ABC, GCB and UNC, there is still strong heterogeneity in GCB subtype [20].”
ResultOrtega-Molina, A., Boss, I. W., Canela, A., Pan, H., Jiang, Y., Zhao, C., Jiang, M., Hu, D., Agirre, X., Niesvizky, I., et al. (2015) · Nature Medicine · doi:10.1038/nm.3943 · Cited by 436 · cited 1×
“In recent years, the role of epigenetic changes in GCBDLBCL progression has received increasing attention [6, 7].”
BackgroundWeighted Gene Coexpression Network Analysis: State of the Art
Zhao, W., Langfelder, P., Fuller, T., Dong, J., Li, A., & Hovarth, S. (2010) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400903572753 · Cited by 396 · cited 1×
“Gene co-expression network analysis is an important method to discover these genes [19].”
MethodFriedberg, J. W., & Fisher, R. I. (2008) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2008.07.002 · Cited by 362
Cited by
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“Three genes ( COL1A1 , COL1A2, EGFR) were identified three times, suggesting that they have superior potential in GC prognosis and may provide a theoretic foundation for improving treatment strategies [15].”
BackgroundD’Incal, C. P., Rossem, K. E. V., Man, K. D., Konings, A., Dijck, A. V., Rizzuti, L., Vitriolo, A., Testa, G., Gozes, I., Berghe, W. V., et al. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01450-8 · Cited by 55
“Moreover, ADNP knockdown in GCB subtypes of B cell lymphoma inhibited proliferation, overall suggesting that epigenetic super-enhancer-medi - ated control of ADNP contributes to GCB-DLBCL progression [164].”
BackgroundLevine, J., Hakim, F., Kooy, R. F., & Gozes, I. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02048-0 · Cited by 23
“Reviewing the ADNP literature from 2019 on (Van Dijck et al. 1993; Bend et al. 2019; Gozes et al. 2019; HacohenKleiman et al. 2019; Ivashko-Pachima and Gozes 2019; Ivashko-Pachima et al. 2019; Kaaij et al. 2019; Kapitansky and Gozes 2019; Karagoz et al. 2019; Leblond et al. 2019; Levine et al. 2019; Mollinedo et al. 2…”
Analysis of super-enhancer using machine learning and its application to medical biology
Hamamoto, R., Takasawa, K., Shinkai, N., Machino, H., Kouno, N., Asada, K., Komatsu, M., & Kaneko, S. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad107 · Cited by 28
“Each ChIP-seq peak or group of peaks is given a read density score, the sorting based on the score value, and those located on a region of graph slope > 1 are defined as SEs [78].”
BackgroundXu, H., Li, Y., Jiang, Y., Wang, J., Sun, H., Wu, W., Lv, Y., Liu, S., Zhai, Y., Tian, L., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.827840 · Cited by 14
“In addition, SE inhibitors (JQ1) used to treat DLBCL suppress the expression of these genes (Li et al., 2021).”
Background
Metadata
- Authors
- Li, X., Duan, Y., & Hao, Y.
- Affiliations
- Shanxi Academy of Medical Sciences (CN)
- Shanxi Provincial Cancer Hospital (CN)
- Shanxi Provincial People’s Hospital (CN)
- Corresponding author
- Hao, Yuxia
- Venue
- BMC Medical Genomics
- Published
- 2021-03-04
- Volume
- 14
- Issue
- 1
- Pages
- 69-69
- ISSN
- 1755-8794 (ISSN-L)
- PMC
- PMC7934469
- OpenAlex
- W3135373303
- Cited by
- 14
- References
- 34
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 3
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Medical Genomics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the research funding for returned overseas students in Shanxi Province (2016-123)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- super-enhancers, prognostic factors, ADNP, H3K27ac, autophagy, BET inhibition, JQ1, gene co-expression network, lymphoma cell proliferation
- MeSH terms
- Rituximab, Super Enhancers, Aged, Azepines, Enhancer Elements, Genetic, Humans, Male, Middle Aged, Prognosis, Triazoles, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Lymphoma, Large B-Cell, Diffuse, Germinal Center, Cell Line, Tumor, Cell Proliferation, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis. https://app.cochat.ai/papers/10.1186/s12920-021-00916-z
- The paper
- Li, X., Duan, Y., & Hao, Y. (2021). Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis. BMC Medical Genomics. https://doi.org/10.1186/s12920-021-00916-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.